TITLE

Comparison of Cardiovascular Event Rates in Patients Without Cardiovascular Disease in Whom Atorvastatin or Simvastatin Was Newly Initiated

AUTHOR(S)
Jacobson, Terry A.; Wertz, Debra A.; Hoy, Tracey; Kuznik, Andreas; Grochulski, Daniel; Cziraky, Mark
PUB. DATE
December 2008
SOURCE
Mayo Clinic Proceedings;Dec2008, Vol. 83 Issue 12, p1316
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To compare cardiovascular (CV) event rates and risk in patients without previous CV disease in whom atorvastatin or simvastatin was newiy initiated in a managed care setting. PATIENTS AND METHODS: Patients aged 18 to 64 years in whom atorvastatin or simvastatin was newly initiated between January 1, 2003, and December 31, 2006, and who had no history of CV disease and at least 12 months of preindex and 3 months of postindex continuous eligibility in a managed care health plan, were identified using administrative claims from the HealthCore integrated Research Database. Descriptive statistics were reported for sample characteristics. Unadjusted CV event rates were compared between treatment groups. A multivariate Cox proportional hazards model was developed to evaluate adjusted CV risk in au patients, as well as in a subset of patients with diabetes meliltus. RESULTS: A total of 168,096 patients in the atorvastatin group and 51,333 patients in the simvastatin group were analyzed. Mean ± SD age was 50.2±9.0 years for patients using atorvastatin and 50.6±9.0 years for patients using simvastatin. Mean ± SD follow-up time was 664.2±386.2 days for the atorvastatin group and 511.4±359.8 days for the simvastatin group. Mean ± SD dose and mean ± SD therapy duration for patients taking simvastatin were 29.1±15.1 mg and 188.6±236.3 days, respectively, compared with 16.8±11.1 mg and 241.8±292.0 days, respectively, for patients taking atorvastatin. Unadjusted CV event rates were lower with use of atorvastatin than with simvastatin (hazard ratio, 0.80; 95% confidence interval, 0.75-0.84; P<.0O1). Adjusting for demographic/clinical characteristics, patients taking atorvastatin experienced a 13% risk reduction in total CV events during the entire follow-up period compared with those who were taking simvastatin (hazard ratio, 0.87; 95% confidence interval, 0.82-0.92; P<.0.01). No significant differences In CV events were found between patients taking atorvastatin or simvastatin in the diabetes meilitus subset (n=36,969). CONCLUSION: in a managed care population with no history of CV disease, risk of CV events was lower among patients taking atorvastatin compared with patients taking simvastatin, after adjusting for known baseline differences.
ACCESSION #
35948734

 

Related Articles

  • Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. Gazmararian, Julie A.; Kripalani, Sunil; Miller, Michael J.; Echt, Katharina V.; Junling Ren; Rask, Kimberly; Ren, Junling // JGIM: Journal of General Internal Medicine;Dec2006, Vol. 21 Issue 12, p1215 

    Background: The factors influencing medication adherence have not been fully elucidated. Inadequate health literacy skills may impair comprehension of medical care instructions, and thereby reduce medication adherence.Objectives: To examine the relationship between...

  • Consider cholesterol-lowering therapy for most CHD patients.  // Geriatrics;Feb99, Vol. 54 Issue 2, p58 

    Presents an abstract of the article `Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels,' which appeared in the November 5, 1998 issue of `New England Journal of Medicine.'

  • Recalibration of a Framingham risk equation for a rural population in India. Chow, C. K.; Joshi, R.; Celermajer, D. S.; Patel, A.; Neal, B. C. // Journal of Epidemiology & Community Health;May2009, Vol. 63 Issue 5, p379 

    Background: Coronary heart disease (CHD) risk estimation tools are a simple means of identifying those at high risk in a community and hence a potentially cost-effective strategy for CHD prevention in resource-poor countries. Since India has few local data upon which to develop such a tool de...

  • Physician satisfaction reflects changes in health care landscape. Dean, Val C. // Journal of Family Practice;Oct97, Vol. 45 Issue 4, p319 

    This article addresses several issues reported in a University of Wisconsin Medical School study of physician satisfaction comparing one community's experience with both health maintenance organizations and fee-for-service payers. It discusses the importance of integrated multispecialty...

  • New quality yardsticks for HEDIS.  // Medical Economics;9/2/2005, Vol. 82 Issue 17, p16 

    Reports that the National Committee for Quality Assurance has added measures to its Health Plan Employer Data and Information Set in the United States. Use of the tool to define how healthcare quality is measured in several areas of clinical care and customer service; Efforts to address the...

  • Estimated Deaths Attributable to Variations in Health Care.  // JNCI: Journal of the National Cancer Institute;11/3/2004, Vol. 96 Issue 21, p1569 

    Presents the 2004 annual report of the United States National Committee for Quality Assurance, on the quality of medical care delivered to people with health plans. Improvement of medical care compared to the previous year; Estimate of premature deaths every year attributed to unexplained...

  • Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study. Zengin, Elvin; Bickel, Christoph; Schnabel, Renate B.; Zeller, Tanja; Lackner, Karl-J.; Rupprecht, Hans-J.; Blankenberg, Stefan; Westermann, Dirk; null, null // PLoS ONE;7/8/2015, Vol. 10 Issue 7, p1 

    Background: Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We aimed to compare the traditional risk factors to clinical variables for the prediction of secondary cardiovascular events. Methods and Results: For this study, 3229 patients with...

  • The Relationship Between the Stages of Change for Exercise and Health Insurance Costs. Dunnagan, Tim; Haynes, George; Smith, Vince // American Journal of Health Behavior;Sep/Oct2001, Vol. 25 Issue 5, p447 

    No abstract available.

  • Sensing danger. Frabotta, David // Managed Healthcare Executive;May2003, Vol. 13 Issue 5, p33 

    Reports on the partnership between public health entities and private managed care systems to track public health trends in the U.S. Evolution of the systems that monitor bioterrorism; Creation of a real-tim reporting network that monitors syndromes based on geographic areas; Details on the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics